Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy
| Autor: | Marleen M.H.J. van Gelder, Anick Bérard, Mollie Wood, Hedvig Nordeng, Sengwee Toh, Susan E. Andrade |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
030226 pharmacology & pharmacy Administrative claims data Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] 03 medical and health sciences 0302 clinical medicine Pregnancy Epidemiology Health care medicine Electronic health records 030212 general & internal medicine Medical prescription Birth registry Data collection business.industry Pharmacoepidemiology Gestational age medicine.disease 3. Good health Data quality General Earth and Planetary Sciences Medical emergency Reproductive and Perinatal Epidemiology (R Platt Section Editor) business |
| Zdroj: | Current Epidemiology Reports Current Epidemiology Reports, 4, pp. 106-116 Current Epidemiology Reports, 4, 106-116 |
| ISSN: | 2196-2995 |
| Popis: | Purpose of Review Administrative claims databases, which collect reimbursement-related information generated from healthcare encounters, are increasingly used to evaluate medication safety in pregnancy. We reviewed the strengths and limitations of claims-only databases and how other data sources may be used to improve the accuracy and completeness of information critical for studying medication safety in pregnancy. Recent Findings Research on medication safety in pregnancy requires information on pregnancy episodes, mother-infant linkage, medication exposure, gestational age, maternal and birth outcomes, confounding factors, and (in some studies) long-term follow-up data. Claims data reliably identifies live births and possibly other pregnancies. It allows mother-infant linkage and has prospectively collected prescription medication information. Its diagnosis and procedure information allows estimation of gestational age. It captures maternal medical conditions but generally has incomplete data on reproductive and lifestyle factors. It has information on certain, typically short-term maternal and infant outcomes that may require chart review confirmation. Other data sources including electronic health records and birth registries can augment claims data or be analyzed alone. Interviews, surveys, or biological samples provide additional information. Nationwide and regional birth and pregnancy registries, such as those in several European and North American countries, generally contain more complete information essential for pregnancy research compared to claims-only databases. Summary Claims data offers several advantages in medication safety in pregnancy research. Its limitations can be partially addressed by linking it with other data sources or supplementing with primary data collection. Rigorous assessment of data quality and completeness is recommended regardless of data sources. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink